Publication

TCF4 promotes erythroid development

Hout, F. E. M. I., van Duren, J., Monteferrario, D., Brinkhuis, E., Mariani, N., Westers, T. M., Chitu, D., Nikoloski, G., van de Loosdrecht, A. A., van der Reijden, B. A., Jansen, J. H. & Huls, G., Jan-2019, In : Experimental Hematology. 69, p. 17-21 5 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

  • TCF4 promotes erythroid development

    Final publisher's version, 1.02 MB, PDF document

    Request copy

DOI

  • Florentien E. M. In't Hout
  • Jolanda van Duren
  • Davide Monteferrario
  • Emma Brinkhuis
  • Niccolo Mariani
  • Theresia M. Westers
  • Dana Chitu
  • Gorica Nikoloski
  • Arjan A. van de Loosdrecht
  • Bert A. van der Reijden
  • Joop H. Jansen
  • Gerwin Huls

Transcription factor 4 (TCF4) is implicated in lymphoid cell differentiation and its expression predicts outcome in acute myeloid leukemia. Here, we investigated the role of TCF4 in myelopoiesis. Overexpression of TCF4 (TCF4(OE)) in umbilical cord blood (UCB) cells resulted in a twofold increase in erythroid colony forming units (CFU-Es), whereas knock-down (KD) of TCF4 (TCF4(KD) ) caused a dramatic decrease in the number of erythroid colonies. In megakaryocyte CFUs (CFU-MKs), both TCF4(KD) and TCF4(OE) inhibited MK colony formation. TCF4 did not have an impact on granulocyte, macrophage, or granulocyte-macrophage colonies or on the proportion of MK-erythrocyte progenitors (MEPs) in culture. Because TCF4 affects erythroid/MK development and these lineages are affected in myelodysplastic syndrome (MDS), we studied the impact of TCF4 expression in this disease. MDS patients with high (>= median) TCF4 mRNA expression had higher hemoglobin (Hb) levels than MDS patients with low TCF4 expression (mean 9.0 vs. 8.55 g/dL, p = 0.02). Overall, TCF4 mRNA expression was lower in hematopoietic stem cells, common myeloid progenitors, and MEPs from MDS patients, but not in granulocyte-macrophage progenitors, compared with healthy controls. Therefore, in cell fractions with erythroid lineage potential, TCF4 is expressed less in MDS patients than in healthy controls. This correlates with the low overall Hb levels seen in MDS patients compared with healthy individuals and is consistent with the positive impact of TCF4 on erythroid development while not having impact on white colonies. These results indicate a role for TCF4 as a novel factor in erythroid-megakaryocytic differentiation.

Original languageEnglish
Pages (from-to)17-21
Number of pages5
JournalExperimental Hematology
Volume69
Publication statusPublished - Jan-2019

    Keywords

  • TRANSCRIPTION FACTOR E2-2, FETAL-HEMOGLOBIN, CELL FATE, EXPRESSION, REPRESSION, SCL/TAL1, NETWORK

ID: 78765311